MarketPulse

market adoption

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Medidata Earns Top 'Luminary' AI Rating as Solutions Back 80% of FDA Drug Approvals

Medidata secures top 'Luminary' AI rating from Everest Group, supporting 80% of FDA approvals with up to 37% faster patient enrollment.
DASTYagentic AIclinical development
The Motley FoolThe Motley Fool··Adam Spatacco

Analyst Projects $250B Robotaxi Revenue for Tesla by 2035, But Key Risks Remain

Analyst projects Tesla's Robotaxi could generate $250B annual revenue by 2035, but significant risks remain including uncertain market adoption and high capital requirements before profitability.
GOOGGOOGLTSLAvaluationcapital expenditure